Endocrine and liver interaction: the role of endocrine pathways in NASH

P Loria, L Carulli, M Bertolotti, A Lonardo - … reviews Gastroenterology & …, 2009 - nature.com
This article reviews evidence that causally links hormonal disorders with hepatobiliary
disease, and gives particular focus to nonalcoholic steatohepatitis (NASH). The downstream …

[HTML][HTML] Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis

SQ Yue, YL Yang, KF Dou, KZ Li - World journal of …, 2003 - ncbi.nlm.nih.gov
AIM: To investigate the expression of proliferating cell nuclear antigen (PCNA) and
CD44mRNA in colorectal cancer with venous invasion and its relationship with liver …

Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment

B Spee, LC Penning, TS van den Ingh, B Arends… - Comparative …, 2005 - Springer
Background We analyzed two spontaneous dog diseases characterized by subnormal portal
perfusion and reduced liver growth:(i) congenital portosystemic shunts (CPSS) without …

[HTML][HTML] 注重神经肽在肝硬化营养障碍和糖代谢紊乱中的作用研究

陈仕珠 - 世界华人消化杂志, 2005 - wjgnet.com
涉及HC 营养不良和糖代谢紊乱的神经肽不下20 种, 主要有: 胰岛素样生长因子(IGFs), 胰升糖素,
生长激素(GH), 神经肽Y, 前列腺素E (PGE), 甘丙肽, 缩胆囊素, 瘦素, 黑色素-浓集激素等 …

肝硬化患者治疗前后可溶性细胞间黏附分子-1 水平变化及其临床意义

庄明明, 问奕欣, 洪晓鹏, 郑卫军 - 国际放射医学核医学杂志, 2005 - ijrmnm.com
目的: 探讨肝硬化患者治疗前后血清可溶性细胞间黏附分子-1 (sICAM-1) 水平变化与肝细胞损伤
的关系. 方法: 用酶联免疫吸附试验检测50 例肝硬化患者和20 例正常对照者血清sICAM-1 水平 …

[引用][C] 重组人生长激素对促进肝硬化大鼠肝脏蛋白质合成的机制

迟强, 张新宇, 王建军, 邰升, 周令望, 曲晓菊, 郭惠丽… - 中华实验外科杂志, 2006

[引用][C] 谷氨酰胺和生长激素联合应用在疾病治疗中的作用

闫忠芳, 齐玉梅 - 国际内科学杂志, 2008

[引用][C] 肝硬化患者血浆ET-1, NO 和黏附分子的水平变化及临床意义

王伯良, 刘勇, 付国强, 仲月霞, 曹义战, 江伟 - 临床消化病杂志, 2007

[引用][C] 器官移植患者的营养支持

刘敦贵 - 中国临床营养杂志, 2005

[引用][C] 重组人生长激素对肝硬化大鼠肝脏蛋白质代谢的影响

迟强, 张新宇, 邰升, 周令望, 曲晓菊, 郭惠丽 - 中国临床营养杂志, 2005